701-40-6

Basic information

• Product Name: 3-Pyridinecarboxylicacid,5-fluoro-,hydrazide(9CI)
• Synonyms: 3-Pyridinecarboxylicacid,5-fluoro-,hydrazide(9CI);5-FLUORONICOTINOHYDRAZIDE
• CAS NO: 701-40-6
• Molecular Formula: C₆H₆FN₃O
• Molecular Weight: 0
• Product Categories: HYDRAZINE
• Mol File: 701-40-6.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Density: 1.356g/cm³
• Refractive Index: 1.557
• CAS DataBase Reference: 3-Pyridinecarboxylicacid,5-fluoro-,hydrazide(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinecarboxylicacid,5-fluoro-,hydrazide(9CI)(701-40-6)
• EPA Substance Registry System: 3-Pyridinecarboxylicacid,5-fluoro-,hydrazide(9CI)(701-40-6)

Safety Data

• Hazardous Substances Data: 701-40-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C6H6FN3O/c7-5-1-4(2-9-3-5)6(11)10-8/h1-3H,8H2,(H,10,11)

Upstream product

• 22620-29-7 Ethyl 5-fluoronicotinate 
• 455-70-9 5-fluoro-3-pyridinecarboxylic acid methyl ester 

Downstream Products

• 107756-01-4 C₁₃H₁₂FN₃O₃S 
• 39891-04-8 5-fluoropyridine-3-carboxaldehyde 
• 118420-35-2 N-[3-(5-fluoro-pyridin-3-yl)acryloyl]-4-(4-diphenylmethyl-1-piperazinyl)butylamine 

Relevant articles and documents

[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES

The present invention covers [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds of general formula (I) in which R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of cancer or conditions with dysregulated immune responses or other disorders associated with aberrant AHR signaling, as a sole agent or in combination with other active ingredients.

P2X7 MODULATORS

The present invention is directed to a compound of Formula (I) and to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.

Pyridine compounds, process for the preparation thereof and pharmaceutical composition containing the same

The present invention relates to novel pyridine compounds having antiallergic activity mainly through 5-lipoxygenase inhibitory activity, antihistamine activity and/or inhibiting activity against chemical mediator release